Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA
Go back to Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA| Otter Lake Resources, Inc. New (NASDAQ: OTLK) | Delayed: 1.70 -0.13 (7.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.83 | 52 Week High | $0.03 | |||
| Open | $1.74 | 52 Week Low | $0.01 | |||
| Day High | $1.87 | P/E | N/A | |||
| Day Low | $1.69 | EPS | $0.00 | |||
| Volume | 10,753,322 | |||||
